BRIEF published on 09/18/2024 at 12:05, 2 days 15 hours ago Multitude PLC se transforme avec succès en société anonyme Société Anonyme Fintech Prêts Numériques Banque En Ligne Conversion D'entreprise
BRIEF published on 09/18/2024 at 12:05, 2 days 15 hours ago Multitude P.L.C. Successfully Converts to Public Limited Company Fintech Digital Lending Online Banking Public Limited Company Corporate Conversion
PRESS RELEASE published on 09/18/2024 at 12:00, 2 days 15 hours ago Multitude P.L.C.: Completion of conversion of the Company into a public limited company Multitude P.L.C. completed conversion to public limited company in Malta. Offers digital lending and online banking services to various sectors. LEI, ISIN, and WKN remain unchanged Digital Lending Online Banking Conversion Public Limited Company Multitude P.L.C.
BRIEF published on 09/05/2024 at 17:20, 15 days 9 hours ago L'assemblée générale extraordinaire de Multitude PLC approuve la redomiciliation en Suisse Suisse Fintech Redomiciliation EGME PLC À Multiples Fonctions
BRIEF published on 09/05/2024 at 17:20, 15 days 9 hours ago Extraordinary General Meeting of Multitude P.L.C. Approves Redomiciliation to Switzerland Switzerland EGM Fintech Redomiciliation Multitude P.L.C.
PRESS RELEASE published on 09/05/2024 at 17:15, 15 days 10 hours ago Extraordinary General Meeting of Multitude P.L.C. approves the redomiciliation of the Company to Switzerland Multitude P.L.C.'s Extraordinary General Meeting approves redomiciliation to Switzerland, complying with Maltese and Swiss laws. Details on the Company's website Switzerland EGM Fintech Redomiciliation Multitude P.L.C.
BRIEF published on 08/22/2024 at 07:35, 29 days 19 hours ago Multitude SE Continues Strong Growth in 2024: EBIT Increases 34.5% to EUR 28.3 Million During H1 2024 Revenue Increase Risk Management EBIT Growth Business Units Profit Stability
BRIEF published on 08/22/2024 at 07:35, 29 days 19 hours ago Multitude SE poursuit sa forte croissance en 2024 : l'EBIT augmente de 34,5 % à 28,3 millions d'euros au cours du premier semestre 2024 Gestion Des Risques Augmentation Des Revenus Croissance Du Résultat D'exploitation (EBIT) Unités Commerciales Stabilité Des Bénéfices
PRESS RELEASE published on 08/22/2024 at 07:30, 29 days 19 hours ago Multitude SE continues strong growth in 2024: EBIT increases 34.5% to EUR 28.3 million during H1 2024 Multitude SE reports strong growth in H1 2024: EBIT up by 34.5% to EUR 28.3 million, revenue increases by 17.0% to EUR 128.8 million. Positive development in all business units Revenue Growth EBIT Multitude SE H1 2024 Business Units
BRIEF published on 08/21/2024 at 16:36, 30 days 10 hours ago Les actionnaires de Multitude SE approuvent la conversion en société anonyme Assemblée Générale Extraordinaire Société Anonyme Fintech Multitude SE Redomiciliation
Published on 09/20/2024 at 23:40, 3 hours 35 minutes ago Integrated BioPharma Reports Results for Its Quarter and Fiscal Year Ended June 30, 2024
Published on 09/20/2024 at 23:30, 3 hours 45 minutes ago Final Bell Holdings International Ltd. Announces Sale of Final Bell Corp.
Published on 09/20/2024 at 23:00, 4 hours 15 minutes ago AI/ML Innovations Inc. Provides Second Status Update
Published on 09/20/2024 at 22:30, 4 hours 45 minutes ago Electric Metals Announces Changes to its Board of Directors
Published on 09/20/2024 at 22:15, 5 hours ago Torq Clarifies Finder’s Warrant Exercise Price of $0.10 Financing
Published on 09/20/2024 at 22:58, 4 hours 17 minutes ago Freelance.com: Mise à disposition du Document d’Enregistrement Universel 2023
Published on 09/20/2024 at 21:00, 6 hours 15 minutes ago Aurubis celebrates ribbon-cutting at the first multimetal recycling plant in the United States
Published on 09/20/2024 at 19:50, 7 hours 25 minutes ago BRAIN Biotech AG concludes major pharma compound transaction valued up to EUR 128.88 million from its BioIncubator
Published on 09/20/2024 at 19:47, 7 hours 28 minutes ago EQS-Adhoc: BRAIN Biotech AG concludes royalty monetization deal for up to EUR 128.88 million on investigational pharma compound deucrictibant with Royalty Pharma
Published on 09/20/2024 at 17:40, 9 hours 35 minutes ago Availability of the 2024 Half-Year Financial Report
Published on 09/20/2024 at 17:40, 9 hours 35 minutes ago Mise à disposition du Rapport Financier Semestriel 2024